» Articles » PMID: 12975311

Representational Oligonucleotide Microarray Analysis: a High-resolution Method to Detect Genome Copy Number Variation

Abstract

We have developed a methodology we call ROMA (representational oligonucleotide microarray analysis), for the detection of the genomic aberrations in cancer and normal humans. By arraying oligonucleotide probes designed from the human genome sequence, and hybridizing with "representations" from cancer and normal cells, we detect regions of the genome with altered "copy number." We achieve an average resolution of 30 kb throughout the genome, and resolutions as high as a probe every 15 kb are practical. We illustrate the characteristics of probes on the array and accuracy of measurements obtained using ROMA. Using this methodology, we identify variation between cancer and normal genomes, as well as between normal human genomes. In cancer genomes, we readily detect amplifications and large and small homozygous and hemizygous deletions. Between normal human genomes, we frequently detect large (100 kb to 1 Mb) deletions or duplications. Many of these changes encompass known genes. ROMA will assist in the discovery of genes and markers important in cancer, and the discovery of loci that may be important in inherited predispositions to disease.

Citing Articles

Genomic complexity and clinical significance of the RCCX locus.

Shiryagin V, Devyatkin A, Fateev O, Petriaikina E, Bogdanov V, Antysheva Z PeerJ. 2024; 12:e18243.

PMID: 39512309 PMC: 11542561. DOI: 10.7717/peerj.18243.


Advancements in copy number variation screening in herbivorous livestock genomes and their association with phenotypic traits.

Liu X, Chen W, Huang B, Wang X, Peng Y, Zhang X Front Vet Sci. 2024; 10:1334434.

PMID: 38274664 PMC: 10808162. DOI: 10.3389/fvets.2023.1334434.


Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing.

Tendi E, Morello G, Guarnaccia M, La Cognata V, Petralia S, Messina M Biomedicines. 2023; 11(7).

PMID: 37509538 PMC: 10377317. DOI: 10.3390/biomedicines11071899.


Genetic variation in placental insufficiency: What have we learned over time?.

Wang L, Fernandez-Boyano I, Robinson W Front Cell Dev Biol. 2022; 10:1038358.

PMID: 36313546 PMC: 9613937. DOI: 10.3389/fcell.2022.1038358.


Tool and techniques study to plant microbiome current understanding and future needs: an overview.

Enespa , Chandra P Commun Integr Biol. 2022; 15(1):209-225.

PMID: 35967908 PMC: 9367660. DOI: 10.1080/19420889.2022.2082736.


References
1.
Mu D, Chen L, Zhang X, See L, Koch C, Yen C . Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell. 2003; 3(3):297-302. DOI: 10.1016/s1535-6108(03)00054-0. View

2.
Snijders A, Nowee M, Fridlyand J, Piek J, Dorsman J, Jain A . Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene. 2003; 22(27):4281-6. DOI: 10.1038/sj.onc.1206621. View

3.
Healy J, Thomas E, Schwartz J, Wigler M . Annotating large genomes with exact word matches. Genome Res. 2003; 13(10):2306-15. PMC: 403711. DOI: 10.1101/gr.1350803. View

4.
Tkachuk D, Westbrook C, Andreeff M, Donlon T, Cleary M, Suryanarayan K . Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science. 1990; 250(4980):559-62. DOI: 10.1126/science.2237408. View

5.
Lisitsyn N, Wigler M . Cloning the differences between two complex genomes. Science. 1993; 259(5097):946-51. DOI: 10.1126/science.8438152. View